- £561.20m
- £707.99m
- $722.80m
- 64
- 42
- 81
- 70
2019 March 31st | 2020 March 31st | 2021 April 4th | 2022 April 3rd | 2023 April 2nd | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 52 W | 52 W |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 372 | 391 | 443 | 615 | 723 |
Cost of Revenue | |||||
Gross Profit | 73.5 | 90.7 | 104 | 126 | 157 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 359 | 374 | 413 | 574 | 669 |
Operating Profit | 13 | 17.1 | 30.7 | 41 | 53.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.6 | 15.9 | 29.4 | 36.2 | 45.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.21 | 14.7 | 38.9 | 30.4 | 37.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 9.21 | 14.7 | 38.9 | 30.4 | 36.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.21 | 14.7 | 38.9 | 30.4 | 36.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.101 | 0.116 | 0.274 | 0.204 | 0.249 |
Dividends per Share |